Livekindly Collective raises additional $135 million for its plant-based platform

October 15, 2020
Emerging Ecosystems in Agrifood and Health More...
Investment More...
Very important

Blue Horizon Corporation led the round, which brings the company's total funding to $335 million after entering with a $200 million founders' round in March 2020. This latest financing will go toward launching portfolio brands The Fry Family Food Co., LikeMeat, and Oumph!, currently available in parts of Europe, Africa, and Australia, in the U.S., as well as development of new plant-based chicken and egg products. Clients, COVID-19 has given plant-based proteins a boost, especially in the near term. With competitive tension growing, it is imperative to make informed decisions that arrive at a solution with a unique value proposition for your organization and for consumers

For the original news article, click here .

Further Reading

"Molecular coffee" maker Atomo raises $9 million in additional seed funding, bringing its total to $11.6 million

News Commentary | August 12, 2020

Existing investor Horizons Ventures participated, with other noteworthy investors now joining the cap table including S2G Ventures, AgFunder, and Bessemer Venture Partners. The new funding will go toward construction of a production roastery in Seattle, with the company eyeing a commercial launch in... Not part of subscription

Impossible Foods raises $200 million Series G round, bringing total funding to $1.5 billion

News Commentary | August 17, 2020

New investor Coatue led the round, which comes only four months after Impossible raised a $500 million Series F round. Major company updates include over 60× retail footprint expansion in the U.S., increased presence of Impossible Sausage up to 22,000 restaurants, and new items in its R&D ... To read more, click here.

Mycoproteins gain funding momentum as The Protein Brewery raises $22 million Series A

News Commentary | November 12, 2020

This Series A round was led by Novo Holdings, joined by Roquette Ventures and Unovis Asset Management, and will help the Dutch startup to focus on R&D as well as scale up production of its mycoprotein ingredient "Fermotein." It hopes to commercialize Fermotein upon regulatory approval by 2021 in... To read more, click here.